2021 annual financial data
Seres Therapeutics 2021 Operating margin
Direct answer
Operating margin was -44.5%.
Operating income was -64,493,000 USD and net income was -65,578,000 USD.
Operating cash flow was 6,688,000 USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 144,927,000 USD
- Operating income
- -64,493,000 USD
- Net income
- -65,578,000 USD
- Operating cash flow
- 6,688,000 USD